Biogen (BIIB) stock Forecast for 2022 – 2026
Last update: 05-24-2022, 5:55
Sector: HealthcareThe share price of Biogen Inc. (BIIB) now
What analysts predict:: $242
52-week high/low: $468.55 / $187.16
50/200 Day Moving Average: $206.8 / $251.16
This figure corresponds to the average price over the previous 50/200 days. For Biogen stocks, the 50-day moving average is the resistance level today.
For Biogen stocks, the 200-day moving average is the resistance level today.
Are you interested in Biogen Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biogen stock price in 2022, 2023, 2024, 2025, 2026. How much will one Biogen share be worth in 2022 - 2026?
When should I take profit in Biogen stock? When should I record a loss on Biogen stock? What are analysts' forecasts for Biogen stock? What is the future of Biogen stock?
We forecast Biogen stock performance using neural networks based on historical data on Biogen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Biogen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Biogen shares. This happens once a day.
Historical and forecast chart of Biogen stock
The chart below shows the historical price of Biogen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Biogen stock price can be found in the table below.
Long-term forecasts by years.
Biogen daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 26 | 201.51 | 199.33 | 203.68 | 2.18 |
| May 27 | 200.66 | 198.13 | 202.89 | 2.40 |
| May 28 | 196.87 | 194.39 | 200.35 | 3.07 |
| May 29 | 195.27 | 193.40 | 196.86 | 1.79 |
| May 30 | 195.22 | 191.76 | 199.61 | 4.09 |
| May 31 | 195.57 | 192.22 | 199.50 | 3.78 |
| Jun 01 | 192.63 | 189.11 | 194.25 | 2.72 |
| Jun 02 | 192.86 | 189.05 | 194.60 | 2.94 |
| Jun 03 | 195.76 | 193.06 | 198.69 | 2.92 |
| Jun 04 | 194.47 | 190.85 | 197.79 | 3.64 |
| Jun 05 | 191.96 | 190.17 | 196.33 | 3.24 |
| Jun 06 | 197.66 | 194.69 | 202.16 | 3.84 |
| Jun 07 | 199.79 | 198.29 | 204.53 | 3.14 |
| Jun 08 | 196.92 | 193.78 | 200.64 | 3.54 |
| Jun 09 | 194.73 | 192.92 | 198.29 | 2.79 |
| Jun 10 | 197.24 | 192.74 | 199.85 | 3.68 |
| Jun 11 | 194.99 | 193.24 | 199.44 | 3.21 |
| Jun 12 | 194.58 | 190.09 | 197.74 | 4.02 |
| Jun 13 | 192.83 | 188.78 | 196.59 | 4.14 |
| Jun 14 | 190.63 | 186.06 | 192.41 | 3.41 |
| Jun 15 | 192.12 | 189.01 | 196.27 | 3.84 |
| Jun 16 | 193.39 | 189.68 | 197.22 | 3.98 |
| Jun 17 | 197.39 | 195.97 | 200.06 | 2.09 |
| Jun 18 | 202.66 | 199.99 | 203.88 | 1.95 |
| Jun 19 | 201.45 | 199.88 | 203.02 | 1.57 |
| Jun 20 | 202.11 | 200.41 | 206.84 | 3.21 |
| Jun 21 | 200.78 | 196.74 | 202.83 | 3.09 |
| Jun 22 | 199.87 | 196.58 | 201.13 | 2.32 |
| Jun 23 | 197.42 | 193.21 | 199.37 | 3.19 |
| Jun 24 | 192.50 | 188.98 | 195.62 | 3.51 |
Biogen Daily Price Targets
Biogen Stock Forecast 05-26-2022.
Pessimistic target level: 199.33
Optimistic target level: 203.68
Biogen Stock Forecast 05-27-2022.
Pessimistic target level: 198.13
Optimistic target level: 202.89
Biogen Stock Forecast 05-28-2022.
Pessimistic target level: 194.39
Optimistic target level: 200.35
Biogen Stock Forecast 05-29-2022.
Pessimistic target level: 193.40
Optimistic target level: 196.86
Biogen Stock Forecast 05-30-2022.
Pessimistic target level: 191.76
Optimistic target level: 199.61
Biogen Stock Forecast 05-31-2022.
Pessimistic target level: 192.22
Optimistic target level: 199.50
BIIB (BIIB) Monthly Stock Prediction for 2022
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 212.91 | 204.19 | 219.62 | 7.02 |
| Jul. | 221.86 | 208.81 | 239.79 | 12.92 |
| Aug. | 228.38 | 219.03 | 239.41 | 8.51 |
| Sep. | 236.77 | 223.10 | 246.47 | 9.48 |
| Oct. | 222.10 | 207.64 | 233.30 | 11.00 |
| Nov. | 215.34 | 201.77 | 221.67 | 8.98 |
| Dec. | 204.71 | 195.26 | 210.73 | 7.34 |
Biogen forecast for this year
Biogen Stock Prediction for Jun 2022
An uptrend is forecast for this month with an optimal target price of $212.913. Pessimistic: $204.19. Optimistic: $219.62
Biogen Stock Prediction for Jul 2022
An uptrend is forecast for this month with an optimal target price of $221.855. Pessimistic: $208.81. Optimistic: $239.79
Biogen Stock Prediction for Aug 2022
An uptrend is forecast for this month with an optimal target price of $228.378. Pessimistic: $219.03. Optimistic: $239.41
Biogen Stock Prediction for Sep 2022
An uptrend is forecast for this month with an optimal target price of $236.771. Pessimistic: $223.10. Optimistic: $246.47
Biogen Stock Prediction for Oct 2022
An downtrend is forecast for this month with an optimal target price of $222.103. Pessimistic: $207.64. Optimistic: $233.30
Biogen Stock Prediction for Nov 2022
An downtrend is forecast for this month with an optimal target price of $215.34. Pessimistic: $201.77. Optimistic: $221.67
Biogen Stock Prediction for Dec 2022
An downtrend is forecast for this month with an optimal target price of $204.713. Pessimistic: $195.26. Optimistic: $210.73
Biogen (BIIB) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 200.20 | 190.11 | 210.08 | 9.51 |
| Feb | 201.88 | 191.49 | 206.33 | 7.19 |
| Mar | 223.08 | 209.02 | 238.07 | 12.20 |
| Apr | 218.39 | 203.95 | 231.24 | 11.80 |
| May | 196.38 | 190.81 | 212.67 | 10.28 |
| Jun | 210.81 | 197.98 | 217.01 | 8.77 |
| Jul | 225.64 | 208.59 | 237.02 | 12.00 |
| Aug | 235.60 | 224.46 | 253.65 | 11.51 |
| Sep | 259.84 | 250.29 | 273.21 | 8.39 |
| Oct | 273.21 | 252.55 | 283.25 | 10.84 |
| Nov | 300.17 | 276.22 | 319.08 | 13.43 |
| Dec | 323.81 | 302.73 | 335.71 | 9.82 |
Biogen (BIIB) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 291.51 | 280.80 | 316.00 | 11.14 |
| Feb | 288.45 | 278.15 | 310.56 | 10.44 |
| Mar | 276.03 | 260.09 | 295.45 | 11.97 |
| Apr | 265.60 | 253.61 | 285.12 | 11.05 |
| May | 284.00 | 267.01 | 291.76 | 8.48 |
| Jun | 288.78 | 270.28 | 302.72 | 10.72 |
| Jul | 318.19 | 296.80 | 334.89 | 11.37 |
| Aug | 322.20 | 314.08 | 337.76 | 7.01 |
| Sep | 329.30 | 304.41 | 351.78 | 13.47 |
| Oct | 297.49 | 275.00 | 306.86 | 10.38 |
| Nov | 284.06 | 273.62 | 297.48 | 8.02 |
| Dec | 261.99 | 251.81 | 280.69 | 10.29 |
Biogen (BIIB) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 253.46 | 235.10 | 273.15 | 13.93 |
| Feb | 252.13 | 244.45 | 268.54 | 8.97 |
| Mar | 265.37 | 253.11 | 274.84 | 7.91 |
| Apr | 258.40 | 241.85 | 267.08 | 9.45 |
| May | 255.69 | 247.90 | 267.50 | 7.33 |
| Jun | 274.75 | 251.96 | 289.75 | 13.04 |
| Jul | 280.52 | 264.91 | 288.47 | 8.17 |
| Aug | 274.92 | 264.82 | 284.74 | 7.00 |
| Sep | 250.38 | 233.82 | 261.69 | 10.65 |
| Oct | 249.07 | 243.58 | 261.62 | 6.90 |
| Nov | 260.84 | 241.94 | 272.34 | 11.16 |
| Dec | 256.18 | 243.81 | 263.71 | 7.55 |
Biogen (BIIB) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 273.40 | 259.04 | 286.03 | 9.43 |
| Feb | 284.88 | 276.21 | 295.05 | 6.39 |
| Mar | 284.58 | 260.98 | 300.12 | 13.04 |
| Apr | 303.41 | 290.03 | 310.42 | 6.57 |
| May | 299.27 | 276.01 | 314.03 | 12.11 |
| Jun | 306.49 | 298.45 | 319.04 | 6.46 |
| Jul | 314.86 | 303.62 | 337.67 | 10.08 |
| Aug | 314.86 | 297.01 | 321.47 | 7.61 |
| Sep | 301.64 | 293.08 | 316.52 | 7.40 |
| Oct | 296.88 | 282.86 | 304.37 | 7.07 |
| Nov | 296.57 | 277.89 | 308.72 | 9.99 |
| Dec | 279.45 | 268.00 | 292.65 | 8.42 |
Biogen information and performance
Biogen is an international biotechnology company that discovers, develops and provides drugs for the treatment of multiple sclerosis (MS) and other hematological, neurodegenerative, autoimmune and other diseases to patients around the world. Biogen is at the forefront of new drug research for neurological diseases and rare genetic diseases.
The company was founded in Geneva (Switzerland) in 1978 by several renowned and forward-thinking biologists. Later one of the founders, Ph.D. Walter Gilbert, received the Nobel Prize in Chemistry for the DNA sequencing method. And in 1993, another founder, Phillip Sharp, received the Nobel Prize in Physiology or Medicine for discovering and showing that the genes of higher organisms have a “discontinuous” structure.
Biogen Address
225 BINNEY STREET, CAMBRIDGE, MA, US
Market Capitalization: 29 053 149 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: 3 923 400 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: 19.07
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: 8.12
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: 10.4
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: 0.075
Quarterly Revenue Growth YOY: -0.042
Trailing PE: 19.07
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 11.93
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 2.941
Enterprise Value (EV) /Revenue
EV To EBITDA: 11.65
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 146452000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A